Abstract

To evaluate the association of postoperative hemoglobin values and mortality in patients undergoing double- lung transplantation with intraoperative transfusion. Retrospective cohort study. University hospital. Adult patients who underwent double-lung transplantation at the authors' institution, with intraoperative transfusion of packed red blood cells between 2009 and 2015. None. Intraoperative transfusion requirements and general characteristics of 554 patients were collected. A generalized additive model, controlling for postoperative hemoglobin levels, number of transfused units of packed red blood cells, perioperative change in hemoglobin levels, disease leading to lung transplantation, and postoperative extracorporeal membrane oxygenation, was created to predict one-year mortality. A postoperative hemoglobin level of 11.3 g/dL was calculated as an optimal cutoff point. The patients were stratified according to this level. The end -point was all-cause one-year mortality after double-lung transplantation, assessed using the Kaplan-Meier analysis with log-rank test. All-cause mortality of the 554 patients was 17%. Postoperatively, 171 patients (31%) were categorized as being below the cutoff point. Improved survival was observed in the group with higher postoperative hemoglobin values (p = 0.002). Lower postoperative hemoglobin levels in double-lung transplantation recipients were associated with increased mortality during the first year after surgery. Confirmation of these findings in additional investigations could alter patient blood management for double-lung transplantation.

Highlights

  • MethodsThis observational, single-center cohort study was approved by the local ethics committee (EK1144/2015)

  • Initial Postoperative Hemoglobin Values Are Independently Associated With One-Year Mortality in Patients Undergoing Double-Lung Transplantation Requiring Intraoperative Transfusion

  • There was a relationship between prolonged postoperative venoarterial extracorporeal membrane oxygenation (ECMO) and lower postoperative hemoglobin levels

Read more

Summary

Methods

This observational, single-center cohort study was approved by the local ethics committee (EK1144/2015). Because of the retrospective nature of the study, patient consent was waived. The files of all consecutive patients who underwent lung transplantation at the authors’ institution between January 2009 and August 2015 were screened. This cohort was used in a previous study assessing bleeding complications after lung transplantation.[15] Patients younger than 18 years; patients undergoing combined procedures (eg, multiorgan transplantation or cardiac surgery on cardiopulmonary bypass) or singlelung transplantation; patients with incomplete laboratory or transfusion data; patients without intraoperative transfusion of PRBC; and all patients requiring repeat thoracotomy because of bleeding during the first 24 hours after transplantation were excluded (Fig 1). Additional missing data are reported as altered counts whenever they emerged

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call